Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06939088
What this trial is testing

Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder

Who this might be right for
Alcohol Use DisorderAlcohol Abuse/DependenceAlcohol Dependence+5 more
Anders Fink-Jensen, MD, DMSci 108
Not applicableLooking for participantsNCT07361874
What this trial is testing

IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion

Who this might be right for
Mild Autonomous Cortisol Secretion (MACS)Autonomous Cortisol Secretion (ACS)Subclinical Cushing's+1 more
University of Texas Southwestern Medical Center 75
Not applicableStudy completedNCT02381249
What this trial is testing

The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery

Who this might be right for
Esophageal NeoplasmsStomach NeoplasmsWeight Loss+3 more
St. James's Hospital, Ireland 40
Post-approval studies (Phase 4)Study completedNCT01449747
What this trial is testing

Pharmacokinetics Study of Dipeptidyl Peptidase 4 Inhibitor to Control Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
The Catholic University of Korea 24
Not applicableStudy completedNCT00529048
What this trial is testing

Quantification of the Incretin Effect in Healthy Subjects and Patients With Type 2 Diabetes

Who this might be right for
Incretin Effect
Herlev Hospital 16
Post-approval studies (Phase 4)Study completedNCT01208649
What this trial is testing

Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Fatty Liver Disease
Ruhr University of Bochum 13
Not applicableLooking for participantsNCT07702825
What this trial is testing

Magnetic Resonance Imaging Assessment of Multiorgan Health in Obesity

Who this might be right for
Childhood Obesity
Alder Hey Children's NHS Foundation Trust 30
Early research (Phase 1)Study completedNCT05203237
What this trial is testing

Phase 1 Study to Evaluate the Safety and Tolerability of VK2735

Who this might be right for
Weight LossNASH
Viking Therapeutics, Inc. 92
Not applicableLooking for participantsNCT07272837
What this trial is testing

Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass

Who this might be right for
Type 2 DiabetesObesitySemaglutide+2 more
University of Alberta 50
Not applicableUnknownNCT01451905
What this trial is testing

GLP-1 Receptors in Normal Skin and Skin From Patients With Psoriasis

Who this might be right for
Reduction of Psoriasis Following Liraglutide Therapy in Terms of PASI and DLQI
University Hospital, Gentofte, Copenhagen 12
Large-scale testing (Phase 3)Not Yet RecruitingNCT07298915
What this trial is testing

The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED)

Who this might be right for
Obesity & Overweight
University of Virginia 24
Early research (Phase 1)Study completedNCT07455825
What this trial is testing

Investigate the Pharmacokinetics of Different Formulations and Safety of AZD5004 in Healthy Participants Aged 18 to 55 Years

Who this might be right for
Healthy Participants
AstraZeneca 65
Not applicableUnknownNCT02887625
What this trial is testing

Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM

Who this might be right for
Type 2 Diabetes
Dr. Muhammad Abdulghani 410
Large-scale testing (Phase 3)Study completedNCT02404376
What this trial is testing

COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial

Who this might be right for
ST Elevation Acute Myocardial Infarction
Hospital Universitari Vall d'Hebron Research Institute 378
Early research (Phase 1)Not Yet RecruitingNCT07518121
What this trial is testing

A Bridging Study of Efsubaglutide Alfa in Healthy Adults in Brazil

Who this might be right for
Diabete Type 2
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. 48
Not applicableLooking for participantsNCT06668935
What this trial is testing

Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring

Who this might be right for
Diabetes Mellitus
Abbott Diabetes Care 800
Large-scale testing (Phase 3)Study completedNCT00763451
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 484
Large-scale testing (Phase 3)Looking for participantsNCT07284901
What this trial is testing

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Who this might be right for
Obesity With DiabetesOverweight With Diabetes
Kailera 1,156
Large-scale testing (Phase 3)Study completedNCT00707031
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 639
Not applicableLooking for participantsNCT06843512
What this trial is testing

Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication

Who this might be right for
Weight LossFood Selection
Penn State University 25
Next Page